Trailing-twelve-month (TTM) revenue is $767.61 Million with a year-over-year growth of (4.80%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $269,260,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $155,490,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-02 |
| Q1 FY2026Period ended 2026-03-31 | $168,280,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $174,580,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| TTM revenue | $767,610,000 |
Current P/S: $1,396,205,469 market capitalization ÷ $767,610,000 TTM revenue = 1.82x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $174.58M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:58:30.117Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Aerospace Reportable Segment | $168M | $183M | $188M | $241M | $294M | N/A |
| Packaging Reportable Segment | $488M | $533M | $522M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $46M | $41M | $35M | $34M | $34M | $35M |
| Europe | $116M | $161M | $140M | $153M |
$767.61M
$767.61 Million
(4.80%)
vs. $806.31M a year ago (TTM)
(1.15%)
5 Year compound annual growth rate
1 Year
(4.80%)
3 Year
(4.10%)
5 Year
(1.15%)
10 Year
(0.67%)
15 Year
(2.00%)
20 Year
(1.20%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $645.72M | +$14.92M | +2.37% |
| 2024 | $630.80M | ($262.75M) | (29.41%) |
| 2023 | $893.55M | +$9.72M | +1.10% |
| 2022 | $883.83M | +$26.72M | +3.12% |
| 2021 | $857.11M | +$87.14M | +11.32% |
| 2020 |
TTM Growth
(4.80%)
3-Year CAGR
(4.10%)
5-Year CAGR
(1.15%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:58:30.117Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $464M |
| $512M |
| $536M |
| Specialty Products Reportable Segment | $114M | $141M | $174M | $189M | $118M | $110M |
|---|
| $150M |
| Non-US | N/A | N/A | N/A | N/A | N/A | $238M |
|---|
| Other Americas | $12M | $15M | $18M | $25M | $40M | $53M |
|---|
| UNITED STATES | $596M | $640M | $691M | $681M | $692M | $408M |
|---|
| $769.97M |
| +$46.44M |
| +6.42% |
| 2019 | $723.53M | +$18.50M | +2.62% |
| 2018 | $705.03M | ($112.71M) | (13.78%) |
| 2017 | $817.74M | +$23.72M | +2.99% |
| 2016 | $794.02M | ($69.96M) | (8.10%) |
